Skyland Analytics Appoints James C. Mullen, Former Biogen and Patheon CEO, to Advisory Board

BOULDER, Colo., March 9, 2018 /PRNewswire/ -- Skyland Analytics, a leading developer of pharmaceutical manufacturing data management software, announced today the appointment of James C. Mullen to Skyland's Advisory Board.

"Jim Mullen has unique experience in the industry having previously served as CEO of a leading contract manufacturer, and as CEO of a leading innovator in biotechnology," said Robert DiScipio, CEO of Skyland Analytics. "Jim's perspective on the vital role that process data management plays in enabling compliance with FDA guidelines for data integrity, Continued Process Verification and partner management will enhance Skyland's capability to continue to deliver Part-11 compliant software for drug developers and manufacturers."

"The management of drug development and manufacturing data across internal and external manufacturing networks is one of the greatest challenges in our industry, as almost every drug company – global or emerging – relies extensively or exclusively on a contract manufacturer for product supply," said Jim Mullen. "Bob Di Scipio and the Skyland team have valuable experience in this sector having previously developed one of the leading drug manufacturing informatics tools in the industry. I am excited to offer guidance to the team as they create more modern approaches in process data management."

Mullen was most recently the CEO of Patheon, one of the world's largest contract developer/manufacturers of pharmaceuticals. Previously, he served 10 years as CEO and President of Biogen Idec, Inc. His 30-year career includes extensive experience in pharmaceutical and biotech manufacturing, engineering, sales, marketing, mergers and acquisitions. His experience includes biotechnology, pharmaceuticals and specialty chemicals. He holds a Bachelor of Science in Chemical Engineering from Rensselaer Polytechnic Institute, and a Master of Business Administration from Villanova University.


Skyland Analytics develops data analytics and data management software for pharmaceutical, biotech and chemical companies managing manufacturing processes and product quality across internal and external networks. Skyland's recent product release, Skyland PIMS™ equips manufacturers with a simple, validatable, cloud-based workspace for product, process and batch data. This market-leading software enables access across the manufacturing network to essential data that supports monitoring, ad hoc investigations, process analysis, Continued Process Verification (CPV) management and other critical initiatives.

For more about Skyland PIMS™ and other products and services, visit skylandanalytics.net, or contact us at info@skylandanalytics.net. Follow us on LinkedIn here and Twitter here.

CONTACT: Kathleen Di Scipio, kdiscipio@skylandanalytics.net

View original content:http://www.prnewswire.com/news-releases/skyland-analytics-appoints-james-c-mullen-former-biogen-and-patheon-ceo-to-advisory-board-300611230.html

SOURCE Skyland Analytics

More From Press Releases